NinePointTwo Capital’s Astrana Health ASTH Stock Holding History

NinePointTwo Capital’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,596	Closed	-$296K	–	273
2022 Q3	$296K	Hold	7,596	–	–	0.12%	105
2022 Q2	$293K	Hold	7,596	–	–	0.1%	127
2022 Q1	$368K	Buy	7,596 +3,861	+103%	+$199K	0.1%	86
2021 Q4	$274K	Buy	+3,735	New	+$307K	0.09%	116

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

NinePointTwo Capital's ASTH Position: Q4 2022 in Review

NinePointTwo Capital sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 7,596 shares — an estimated $296K sold.

NinePointTwo Capital first reported a position in ASTH in Q4 2021 and held it in 4 quarters. The position peaked at $368K in Q1 2022. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

NinePointTwo Capital reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
NinePointTwo Capital sold 7,596 Astrana Health shares in Q4 2022, an estimated $296K.
NinePointTwo Capital first reported a position in Astrana Health in Q4 2021 and held it in 4 quarters.
NinePointTwo Capital's Astrana Health position peaked at $368K in Q1 2022.
130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.